GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Brii Biosciences Ltd (FRA:7SS) » Definitions » Cash From Other Investing Activities

Brii Biosciences (FRA:7SS) Cash From Other Investing Activities : €-0.61 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Brii Biosciences Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Brii Biosciences's cash from other investing activities for the six months ended in Dec. 2024 was €6.76 Mil. It means Brii Biosciences received €6.76 Mil from other investing activities. Brii Biosciences's cash from other investing activities for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.61 Mil.

Brii Biosciences Cash From Other Investing Activities Historical Data

The historical data trend for Brii Biosciences's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brii Biosciences Cash From Other Investing Activities Chart

Brii Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash From Other Investing Activities
Get a 7-Day Free Trial -0.14 0.67 4.50 13.88 -0.79

Brii Biosciences Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash From Other Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -15.47 3.47 11.25 -7.37 6.76

Brii Biosciences Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brii Biosciences Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of Brii Biosciences's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Brii Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Brii Biosciences Ltd (FRA:7SS) » Definitions » Cash From Other Investing Activities
Comparable Companies
HKSE:06622 HKSE:02511 HKSE:01875 HKSE:06998 HKSE:03681 HKSE:01244 HKSE:02566 HKSE:02898 HKSE:02563 HKSE:02496 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
BRIBF:USA 02137:Hong Kong
Address
No. 1 North Yongtaizhuang Road, 3rd Floor, Building 7, Zhongguancun Dongsheng, International Science Park, Haidian District, Beijing, CHN, 100192
Website
https://www.briibio.com
Brii Biosciences Ltd is a biotechnology company based in China and the United States. It is committed to developing advancing therapies for infectious diseases, such as HBV, HIV, MDR/XDR gram-negative infections, and other illnesses, such as CNS diseases, which have public health burdens in China and around the world. The company's pipeline of products includes more than 10 product candidates that focus on infectious diseases and mental illnesses.

Brii Biosciences Headlines

No Headlines